---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-002048"
form_type: "8-K"
ticker: "KAPA"
cik: "0001962011"
company_name: "Kairos Pharma, LTD."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T02:22:47.990322+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kairos Pharma raises $3.5M in PIPE offering at $1.40/unit with warrants

## Summary
- Raises $3.5M gross from sale of units at $1.40/Common Unit and $1.399/Pre-Funded Unit.
- Each Common Unit includes 1 share and 1.5 Common Warrants exercisable at $1.40 for 5.5 years.
- Insiders enter 90-day lock-up; registration rights for resale of shares and warrant shares.
- Closing expected January 15, 2025; D. Boral Capital and Boustead Securities as co-placement agents.

## SEC filing metadata
- accession: 0001493152-25-002048
- form_type: 8-K
- ticker: KAPA
- cik: 0001962011
- company_name: Kairos Pharma, LTD.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1962011/000149315225002048/0001493152-25-002048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1962011/000149315225002048/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-002048
- JSON: https://secwatch.observer/filing/0001493152-25-002048.json
- Plain text: https://secwatch.observer/filing/0001493152-25-002048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.